Logo image of IBM.DE

INTL BUSINESS MACHINES CORP (IBM.DE) Stock Fundamental Analysis

FRA:IBM - Deutsche Boerse Ag - US4592001014 - Common Stock - Currency: EUR

201.6  +1.4 (+0.7%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to IBM. IBM was compared to 65 industry peers in the IT Services industry. IBM has an excellent profitability rating, but there are concerns on its financial health. IBM is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year IBM was profitable.
In the past year IBM had a positive cash flow from operations.
In the past 5 years IBM has always been profitable.
In the past 5 years IBM always reported a positive cash flow from operatings.
IBM.DE Yearly Net Income VS EBIT VS OCF VS FCFIBM.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

1.2 Ratios

IBM has a Return On Assets (4.39%) which is comparable to the rest of the industry.
IBM has a Return On Equity of 22.06%. This is amongst the best in the industry. IBM outperforms 84.62% of its industry peers.
The Return On Invested Capital of IBM (7.56%) is comparable to the rest of the industry.
IBM had an Average Return On Invested Capital over the past 3 years of 7.26%. This is below the industry average of 10.96%.
The 3 year average ROIC (7.26%) for IBM is below the current ROIC(7.56%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.39%
ROE 22.06%
ROIC 7.56%
ROA(3y)3.74%
ROA(5y)3.83%
ROE(3y)20.94%
ROE(5y)24.07%
ROIC(3y)7.26%
ROIC(5y)6.26%
IBM.DE Yearly ROA, ROE, ROICIBM.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1.3 Margins

The Profit Margin of IBM (9.60%) is better than 90.77% of its industry peers.
In the last couple of years the Profit Margin of IBM has declined.
With an excellent Operating Margin value of 14.68%, IBM belongs to the best of the industry, outperforming 90.77% of the companies in the same industry.
In the last couple of years the Operating Margin of IBM has grown nicely.
IBM has a Gross Margin of 56.65%. This is comparable to the rest of the industry: IBM outperforms 44.62% of its industry peers.
In the last couple of years the Gross Margin of IBM has remained more or less at the same level.
Industry RankSector Rank
OM 14.68%
PM (TTM) 9.6%
GM 56.65%
OM growth 3Y13.36%
OM growth 5Y1.77%
PM growth 3Y-1.4%
PM growth 5Y-10.1%
GM growth 3Y1.05%
GM growth 5Y0.73%
IBM.DE Yearly Profit, Operating, Gross MarginsIBM.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IBM is destroying value.
The number of shares outstanding for IBM has been increased compared to 1 year ago.
The number of shares outstanding for IBM has been increased compared to 5 years ago.
Compared to 1 year ago, IBM has an improved debt to assets ratio.
IBM.DE Yearly Shares OutstandingIBM.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
IBM.DE Yearly Total Debt VS Total AssetsIBM.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

IBM has an Altman-Z score of 3.39. This indicates that IBM is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.39, IBM is in the better half of the industry, outperforming 72.31% of the companies in the same industry.
IBM has a debt to FCF ratio of 4.46. This is a neutral value as IBM would need 4.46 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.46, IBM is in line with its industry, outperforming 47.69% of the companies in the same industry.
A Debt/Equity ratio of 1.83 is on the high side and indicates that IBM has dependencies on debt financing.
IBM's Debt to Equity ratio of 1.83 is on the low side compared to the rest of the industry. IBM is outperformed by 83.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.83
Debt/FCF 4.46
Altman-Z 3.39
ROIC/WACC0.84
WACC9.04%
IBM.DE Yearly LT Debt VS Equity VS FCFIBM.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.3 Liquidity

A Current Ratio of 1.04 indicates that IBM should not have too much problems paying its short term obligations.
The Current ratio of IBM (1.04) is worse than 67.69% of its industry peers.
A Quick Ratio of 1.00 indicates that IBM should not have too much problems paying its short term obligations.
The Quick ratio of IBM (1.00) is worse than 67.69% of its industry peers.
Industry RankSector Rank
Current Ratio 1.04
Quick Ratio 1
IBM.DE Yearly Current Assets VS Current LiabilitesIBM.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

4

3. Growth

3.1 Past

IBM shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.49%.
IBM shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -4.21% yearly.
IBM shows a small growth in Revenue. In the last year, the Revenue has grown by 1.44%.
Measured over the past years, IBM shows a small growth in Revenue. The Revenue has been growing by 1.69% on average per year.
EPS 1Y (TTM)7.49%
EPS 3Y1.19%
EPS 5Y-4.21%
EPS Q2Q%1.29%
Revenue 1Y (TTM)1.44%
Revenue growth 3Y3.05%
Revenue growth 5Y1.69%
Sales Q2Q%0.99%

3.2 Future

IBM is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.16% yearly.
The Revenue is expected to grow by 4.68% on average over the next years.
EPS Next Y4.66%
EPS Next 2Y5.5%
EPS Next 3Y6.12%
EPS Next 5Y7.16%
Revenue Next Year3.47%
Revenue Next 2Y4.12%
Revenue Next 3Y4.23%
Revenue Next 5Y4.68%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IBM.DE Yearly Revenue VS EstimatesIBM.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 20B 40B 60B 80B
IBM.DE Yearly EPS VS EstimatesIBM.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

2

4. Valuation

4.1 Price/Earnings Ratio

IBM is valuated rather expensively with a Price/Earnings ratio of 22.20.
Compared to the rest of the industry, the Price/Earnings ratio of IBM is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 28.79. IBM is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 21.21, which indicates a rather expensive current valuation of IBM.
The rest of the industry has a similar Price/Forward Earnings ratio as IBM.
IBM is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.38, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 22.2
Fwd PE 21.21
IBM.DE Price Earnings VS Forward Price EarningsIBM.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IBM indicates a slightly more expensive valuation: IBM is more expensive than 70.77% of the companies listed in the same industry.
IBM's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 17.26
EV/EBITDA 18.08
IBM.DE Per share dataIBM.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IBM does not grow enough to justify the current Price/Earnings ratio.
IBM has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)4.77
PEG (5Y)N/A
EPS Next 2Y5.5%
EPS Next 3Y6.12%

4

5. Dividend

5.1 Amount

IBM has a Yearly Dividend Yield of 2.80%. Purely for dividend investing, there may be better candidates out there.
IBM's Dividend Yield is a higher than the industry average which is at 7.76.
Compared to an average S&P500 Dividend Yield of 2.51, IBM has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.8%

5.2 History

The dividend of IBM has a limited annual growth rate of 0.83%.
Dividend Growth(5Y)0.83%
Div Incr Years6
Div Non Decr Years6
IBM.DE Yearly Dividends per shareIBM.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

IBM pays out 102.04% of its income as dividend. This is not a sustainable payout ratio.
IBM's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP102.04%
EPS Next 2Y5.5%
EPS Next 3Y6.12%
IBM.DE Yearly Income VS Free CF VS DividendIBM.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B
IBM.DE Dividend Payout.IBM.DE Dividend Payout, showing the Payout Ratio.IBM.DE Dividend Payout.PayoutRetained Earnings

INTL BUSINESS MACHINES CORP

FRA:IBM (4/25/2025, 7:00:00 PM)

201.6

+1.4 (+0.7%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)01-29 2025-01-29/amc
Earnings (Next)04-23 2025-04-23/amc
Inst Owners64.25%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap186.94B
Analysts73.08
Price Target238.04 (18.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.8%
Yearly Dividend5.88
Dividend Growth(5Y)0.83%
DP102.04%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.93%
Min EPS beat(2)2.27%
Max EPS beat(2)3.59%
EPS beat(4)4
Avg EPS beat(4)4.86%
Min EPS beat(4)2.27%
Max EPS beat(4)9.54%
EPS beat(8)8
Avg EPS beat(8)4.73%
EPS beat(12)11
Avg EPS beat(12)3.24%
EPS beat(16)14
Avg EPS beat(16)2.96%
Revenue beat(2)0
Avg Revenue beat(2)-1.29%
Min Revenue beat(2)-1.66%
Max Revenue beat(2)-0.93%
Revenue beat(4)0
Avg Revenue beat(4)-1.04%
Min Revenue beat(4)-1.66%
Max Revenue beat(4)-0.01%
Revenue beat(8)0
Avg Revenue beat(8)-1.1%
Revenue beat(12)4
Avg Revenue beat(12)-0.15%
Revenue beat(16)5
Avg Revenue beat(16)-4.51%
PT rev (1m)-2.83%
PT rev (3m)11.95%
EPS NQ rev (1m)-0.44%
EPS NQ rev (3m)-10.63%
EPS NY rev (1m)-0.18%
EPS NY rev (3m)-0.44%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)-1.52%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-1.59%
Valuation
Industry RankSector Rank
PE 22.2
Fwd PE 21.21
P/S 3.39
P/FCF 17.26
P/OCF 15.82
P/B 7.79
P/tB N/A
EV/EBITDA 18.08
EPS(TTM)9.08
EY4.5%
EPS(NY)9.5
Fwd EY4.71%
FCF(TTM)11.68
FCFY5.79%
OCF(TTM)12.75
OCFY6.32%
SpS59.49
BVpS25.89
TBVpS-41.77
PEG (NY)4.77
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.39%
ROE 22.06%
ROCE 8.85%
ROIC 7.56%
ROICexc 8.79%
ROICexgc 43.5%
OM 14.68%
PM (TTM) 9.6%
GM 56.65%
FCFM 19.63%
ROA(3y)3.74%
ROA(5y)3.83%
ROE(3y)20.94%
ROE(5y)24.07%
ROIC(3y)7.26%
ROIC(5y)6.26%
ROICexc(3y)8.29%
ROICexc(5y)7.07%
ROICexgc(3y)40.75%
ROICexgc(5y)31.79%
ROCE(3y)8.5%
ROCE(5y)7.33%
ROICexcg growth 3Y26.58%
ROICexcg growth 5Y17.04%
ROICexc growth 3Y17.55%
ROICexc growth 5Y7.25%
OM growth 3Y13.36%
OM growth 5Y1.77%
PM growth 3Y-1.4%
PM growth 5Y-10.1%
GM growth 3Y1.05%
GM growth 5Y0.73%
F-Score7
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 1.83
Debt/FCF 4.46
Debt/EBITDA 3.59
Cap/Depr 24.15%
Cap/Sales 1.8%
Interest Coverage 250
Cash Conversion 96.89%
Profit Quality 204.5%
Current Ratio 1.04
Quick Ratio 1
Altman-Z 3.39
F-Score7
WACC9.04%
ROIC/WACC0.84
Cap/Depr(3y)35.46%
Cap/Depr(5y)39.55%
Cap/Sales(3y)2.66%
Cap/Sales(5y)3.73%
Profit Quality(3y)294.17%
Profit Quality(5y)264.98%
High Growth Momentum
Growth
EPS 1Y (TTM)7.49%
EPS 3Y1.19%
EPS 5Y-4.21%
EPS Q2Q%1.29%
EPS Next Y4.66%
EPS Next 2Y5.5%
EPS Next 3Y6.12%
EPS Next 5Y7.16%
Revenue 1Y (TTM)1.44%
Revenue growth 3Y3.05%
Revenue growth 5Y1.69%
Sales Q2Q%0.99%
Revenue Next Year3.47%
Revenue Next 2Y4.12%
Revenue Next 3Y4.23%
Revenue Next 5Y4.68%
EBIT growth 1Y4.79%
EBIT growth 3Y16.81%
EBIT growth 5Y3.49%
EBIT Next Year53.02%
EBIT Next 3Y20.05%
EBIT Next 5Y10.85%
FCF growth 1Y1.63%
FCF growth 3Y7.1%
FCF growth 5Y0.76%
OCF growth 1Y-3.48%
OCF growth 3Y1.67%
OCF growth 5Y-1.86%